Miya ishemiyasi darajasini baholashda gemodializda 2-toifa qandli diabet bilan og'rigan bemorlarda WHOQOL-BREF so'rovnomasi va BNDF neyromarkerining ahamiyati

  • Tibbiyot fanlari nomzodi, gemodializ kafedrasi, O‘zbekiston Respublikasi Sog‘liqni saqlash vazirligini Akademik Ya.X. To‘raqulov nomidagi Respublika ixtisoslashtirilgan endokrinologiya ilmiy-amaliy tibbiyot markazi

DOI

https://doi.org/10.47689/2181-1415-vol5-iss9/S-pp92-98

Kalit so‘zlar

hayot sifati , WHOQOL-BREFis. BNDF , gemodializ

Annotasiya

Ushbu tadqiqot hayot sifatini baholash vositasi bo'lgan WHOQOL-BREF so'rovnomasining ahamiyatini va surunkali buyrak kasalligi (CKD) bilan asoratlangan 2-toifa qandli diabet (T2DM) bilan og'rigan bemorlarda miyadan olingan neyrotrofik omil (BDNF) biomarkerining ahamiyatini baholashga qaratilgan. ) gemodializ olayotganlar. 2019-yil 1-yanvardan 2020-yil 31-dekabrgacha dasturlashtirilgan gemodializdan o‘tayotgan T2DM va III bosqich surunkali buyrak etishmovchiligi (CRF) bo‘lgan jami 90 nafar bemor tekshirildi. Bu bemorlar surunkali miya yarim ishemiyasi (SCI) og‘irligiga qarab uch guruhga bo‘lingan. ). Natijalar shuni ko'rsatdiki, CCI darajasi oshgani sayin, qon zardobida BDNF darajasi nazorat guruhiga nisbatan sezilarli darajada kamaydi. Bundan tashqari, WHOQOL-BREF ko'rsatkichlari va turli klinik, laboratoriya va instrumental ko'rsatkichlar, shu jumladan kasallikning davomiyligi, ochlikdagi glyukoza, glyukozalangan gemoglobin darajasi, BDNF va karotid va vertebral arteriyalarda qon oqimi tezligi o'rtasida sezilarli bog'liqlik aniqlandi. Tadqiqot WHOQOL-BREF so'rovining ushbu bemor populyatsiyasining hayot sifatini baholashda muhimligini ta'kidlaydi va BDNFni gemodializdan o'tayotgan T2DM bemorlarida miya ishemiyasi uchun qimmatli marker sifatida aniqlaydi.

Ko'chirildi

Kuchirilganligi haqida ma'lumot yuk.

Bibliografik manbalar

Dedov I.I., Melnichenko G.A. /Endocrinology. National guidelines//Moscow,2009., p. 597.

Kadyrova I.A., Mindubaeva F.A., Grizhibovsky A.M. Systematic review of methods for predicting the outcome of cerebral stroke // Human ecology. 2015. No. 10. P. 55-64.

Filimonova T.A., Karakulova Yu.V. The role of a brain-derived neurotrophic factor in the formation of diabetic foot syndrome. Neurological Bulletin. Volume L, issue 2. Kazan, "Medicine", 2018, pp. 111-112.

Adriana Kubis-Kubiak, Aleksandra Dyba,Agnieszka Piwowar.The Interplay between Diabetes and Alzheimer's Disease-In the Hunt for Biomarkers.//Int J Mol Sci. 2020 Apr 15;21(8):2744.doi: 10.3390/ijms21082744.

Chenyang Qi, Xing Mao, Zhigang Zhang Huijuan Wu.Classification and Differential Diagnosis of Diabetic Nephropathy //J Diabetes Res 2017;2017:8637138. doi: 10.1155/2017/8637138. Epub 2017 Feb 20.PMID: 28316995 PMCID:PMC5337846DOI:10.1155/2017/8637138

Huan Yu, Hui Li, Xiaoqian Liu, Xiaoli Du. Levels of serum S100B are associated with cognitive dysfunction in patients with type 2 diabetes //Aging (Albany NY) 2020 Feb 29;12(5):4193-4203.doi: 10.18632/aging.102873. Epub 2020 Feb 29. DOI:10.18632/aging.102873

Jiali Wang, Qianqian Han, Lijun Zhao, Junlin Zhang, et all. Identification of clinical predictors of diabetic nephropathy and non-diabetic renal disease in Chinese patients with type 2 diabetes, with reference to disease course and outcome// Acta Diabetol. 2019 Aug;56(8):939-946. doi:10.1007/s00592-019-01324-7. Epub 2019 Mar 29.

Luca Zazzeroni, Gianandea Pasquinelli, Eleonora Nanni, Valeria Cremonini, Ivan Rubbi Comparison of Quality of Life in Patients Undergoing Hemodialysis and Peritoneal Dialysis: A Systematic Review and Meta-Analysis Review Kidney Blood Press Res 2017;42(4):717-727. doi: 10.1159/000484115. Epub 2017 Oct 19PMID: 29049991 DOI:10.1159/000484115

Levey AS, Coresh J., Balk E., Kausz AT, Levin A., Steffes MW, Hogg RJ, Perrone RD, Lau J., Eknoyan G.; National Kidney Foundation. National Kidney Foundation practice guidelines for chronic kidney disease: evaluation, classification, and stratification // Ann Intern Med. – 2003. – V. 139, N. 2. – p. 137-47.

Sinclair AJ, Girling AJ, Bayer A (2000) Cognitive dysfunction in older subjects with diabetes mellitus: impact on diabetes self-management and use of care services. Diabetes Res Clin Pract 50:203–212

Yuklashlar

85 27

Nashr qilingan

Miya ishemiyasi darajasini baholashda gemodializda 2-toifa qandli diabet bilan og'rigan bemorlarda WHOQOL-BREF so'rovnomasi va BNDF neyromarkerining ahamiyati

Qanday qilib iqtibos keltirish kerak

Xoliqov , A. (2024). Miya ishemiyasi darajasini baholashda gemodializda 2-toifa qandli diabet bilan og’rigan bemorlarda WHOQOL-BREF so’rovnomasi va BNDF neyromarkerining ahamiyati. Jamiyat Va Innovatsiyalar, 5(9/S), 92–98. https://doi.org/10.47689/2181-1415-vol5-iss9/S-pp92-98